Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma-Reference-Cited by-同舟云学术

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Published:2016-03 Issue:1 Volume:165 Page:35-44
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Hugo Willy,Zaretsky Jesse M.,Sun Lu,Song Chunying,Moreno Blanca Homet,Hu-Lieskovan Siwen,Berent-Maoz Beata,Pang Jia,Chmielowski Bartosz,Cherry Grace,Seja Elizabeth,Lomeli Shirley,Kong Xiangju,Kelley Mark C.,Sosman Jeffrey A.,Johnson Douglas B.,Ribas Antoni,Lo Roger S.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference45 articles.

1. Comprehensive molecular characterization of human colon and rectal cancer;Nature,2012

2. Genomic Classification of Cutaneous Melanoma;Cell,2015

3. Comprehensive molecular characterization of clear cell renal cell carcinoma;Nature,2013

4. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

5. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression;Chen;Nat. Commun.,2014

Cited by 2398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for breast cancer: New strategies to enhance the patient selection and overcome therapeutic resistance;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. A multi-task deep learning model based on comprehensive feature integration and self-attention mechanism for predicting response to anti-PD1/PD-L1;International Immunopharmacology;2024-12

3. Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy;International Immunopharmacology;2024-11

4. Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma;Translational Oncology;2024-11

5. Overcoming therapy resistance in pancreatic cancer: New insights and future directions;Biochemical Pharmacology;2024-11